Dr. Petra Jantzer

Companies that do more M&A deliver better shareholder returns, as the data has proven again and again. But what do those that succeed at integration do differently? And how can companies with bold M&A ambitions but less of a track record keep up? Explore the 10 key steps we’ve identified that the best integrators consistently follow. https://atbain.co/4bKbaBz

3

Explore the groundbreaking potential of #quantumcomputing in drug discovery. In the latest episode of the #StrategyandInsider podcast, Bayer’s Bijoy Sagar shares his perspective on the transformative force that is revolutionizing the pharma landscape:

5

Three quarters of transformations fail. So what do you need to do differently to make yours successful? My colleagues at BCG Henderson Institute have defined the five factors that make transformations successful - based on extensive analysis spanning 20 years of global corporate transformation data. Five Truths and a Lie About Corporate Transformations ⬇

4

Incredibly excited to share BCG has been recognized as a Leader in AI Services by Forrester, an independent research firm, in The Forrester Wave™: AI Services, Q2 2024. According to Forrester, "BCG challenges its clients’ assumptions of AI impact by developing innovative AI solutions with a pragmatic approach led by business expertise. It has a healthy AI business with recognizable logos and a growing segment of long-term AI clients." Here is what sets BCG apart, according to Forrester: “Its vision stands out, focused on its clients becoming more competitive with AI while bringing notable clarity about the investments in areas such as R&D, technical development, talent quality, and sector-specific capabilities.” See the full Forrester report: https://on.bcg.com/4bjMShG 

23

1 Kommentar

AI and GenAI have been crucial technologies for healthcare, biopharma, and life sciences, and they continue to disrupt them positively. We have also already seen AI’s impact on developing, producing, and commercialising new treatments.    As our CEO, Christoph Schweizer, rightly says in a recent article in the Financial Times, we have not seen a topic become as rapidly relevant as Gen AI, and it will only continue to grow in the coming years.    "In my conversations with CEOs, I often advise that companies that can bring strategy and GenAI technology together to work toward defined goals and outcomes will quickly gain ground over slower-moving competitors."   Read the article (albeit it is behind a paywall): https://lnkd.in/eNqiJJcX   BCG X #AI #Healthcare

27

1 Kommentar

Redesigning and optimizing distribution networks can unlock significant value. And it can help lower carbon emissions. Discover in the video below how a global MedTech leader achieved significant results by leveraging Boston Consulting Group (BCG)’s SNOW AI network optimization engine. #SupplyChain #Manufacturing #Climate

69

8 Kommentare

The first session is about unmet medical needs- and the new ISPOR working vision. A world where healthcare is accessible, effective, efficient, and affordable for all. Would you like to work with us towards that vision SmartStep Consulting ? And thinking about AI can support us on that ambitious journey? #euhta #marketaccess #AI

18

🧠 𝗔𝗻 𝗶𝗻𝘁𝗲𝗿𝗲𝘀𝘁𝗶𝗻𝗴 𝗿𝗲𝗮𝗱! This systematic review maps the applications researched and ethical landscape emerging related to the use of LLMs in medicine and healthcare! Here’s a summary: 𝗙𝗼𝘂𝗿 𝗯𝗿𝗼𝗮𝗱 𝗟𝗟𝗠 𝗮𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝗲𝗺𝗲𝗿𝗴𝗲𝗱 in the review: 👉 Applications to Support Health Professionals & Researchers 👉 Patient Support Applications 👉 Clinical Applications 👉 Public Health 𝗡𝗶𝗻𝗲 𝗿𝗲𝗰𝘂𝗿𝗿𝗶𝗻𝗴 𝗲𝘁𝗵𝗶𝗰𝗮𝗹 𝗶𝘀𝘀𝘂𝗲𝘀 𝗲𝗺𝗲𝗿𝗴𝗲𝗱 across all applications: 👉 Epistemic Values (reliability, transparency, hallucinations) 👉 Therapeutic Relationships 👉 Scientific Integrity 👉 Well-Being/Harm 👉 Fairness/Justice 👉 Safety/Security 👉 Autonomy 👉 Efficiency 👉 Privacy 𝗧𝘄𝗼 𝗼𝗳 𝗺𝘆 𝗰𝗲𝗻𝘁𝘀 𝗲𝗺𝗲𝗿𝗴𝗲𝗱: 👉 Continually mapping the research on LLMs in medicine and healthcare is a must for informing our ethical frameworks and identifying gaps in our understanding. 👉 This helps ensure that as we integrate these technologies, we do so responsibly and effectively. (Source in the comments.)

78

5 Kommentare

Digital transformation in medtech/ healthcare: what are the necessary changes in incentives and mindset? Tell me what you think? #digitalhealth #medtech #ai #eyinmedtech

3

When the stakes are high and regulation is necessarily complex, using digital twins can enable better, faster innovation in medtech. Unlocking the value available can be hard, but getting the transformation right can help organizations create better performing products. Find out more in the latest @McKinsey Operations blog.

1

Data confirms that the strongest predictor of a transformation’s success is how well the company retains, develops, and acquires the right talent and capabilities. Our latest insight explores how companies can avoid three common transformation talent mistakes. #TransformationsThatWork

1

🔬 Our 2024 Health Care and Medicine Tech Trends Has Launched! 🔬 As we navigate the remarkable advancements at the intersection of technology and biology, our latest trend report delves into how these innovations are transforming healthcare and raising important ethical questions. 🧠 Key Highlights: • 𝐁𝐫𝐚𝐢𝐧 𝐅𝐮𝐧𝐜𝐭𝐢𝐨𝐧 𝐁𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐬: Scientists have made significant strides in understanding brain functions, leading to technologies such as brain-controlled devices for mobility in paralysis patients and thought-to-speech conversion systems. These advancements pose new challenges around privacy and ethics, underscoring the need for robust regulatory frameworks. • 𝐂𝐥𝐢𝐦𝐚𝐭𝐞 𝐂𝐡𝐚𝐧𝐠𝐞 𝐚𝐧𝐝 𝐇𝐞𝐚𝐥𝐭𝐡: The pervasive impacts of climate change are challenging public health strategies, necessitating adaptations to address issues such as the spread of disease and lifestyle changes due to extreme weather conditions. • 𝐒𝐞𝐧𝐬𝐨𝐫 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞: Advanced sensors are revolutionizing the way diseases are detected early and monitored continuously, pushing healthcare towards a more proactive, consumer-driven approach. • 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭: Exciting developments include potential vaccines for cancer and cutting-edge gene therapies, offering new hope in the fight against noncommunicable diseases. • 𝐌𝐢𝐜𝐫𝐨𝐛𝐢𝐨𝐦𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡: Insights into various body microbiomes are uncovering their profound impacts on health and disease, opening new avenues for treatment strategies. • 𝐌𝐞𝐧𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬: With mental health crises on the rise, AI-driven digital health services are emerging as alternatives to traditional treatments, though their effectiveness and ethical implications spark debate. 🌐 This report is a must-read for professionals and stakeholders in healthcare, biotechnology, and public health, providing a comprehensive look at current trends and future directions. Access an abridged version here or download the full report from our Future Today Institute website. Congratulations to Christina von Messling and her Future Today Institute team on this remarkable report! #HealthTech #Biotechnology #PublicHealth #Innovation #TrendReport2024

192

7 Kommentare

🚀 Revolutionising Healthcare Administration: #AI’s Role in Addressing a $500 Billion Challenge 🚀 The transformative potential of artificial intelligence in tackling the healthcare sector’s $500 billion administrative costs. This comprehensive analysis by PYMNTS features insights from #DrMichaelGao and other industry experts on how AI is simplifying complex billing processes and enhancing operational efficiencies within healthcare systems. 🔍 The article, part of the "AI Effect" series, investigates how AI can drastically cut overheads while boosting the accuracy of medical billing, ensuring financial sustainability alongside superior patient care. #HealthcareInnovation #ArtificialIntelligence #MedicalBilling #HealthTech

5

It was a great honor to return to MedTech Europe's CEO Summit yesterday to share our perspectives on the decarbonisation pathway for MedTech.    A few of our key messages: The climate crisis is a health crisis and so it is imperative that the healthcare sector does their part to reduce impact on the planet for the good of patients everywhere. Sustainability action is not only a moral duty, but also a sound business decision. Taking action can provide a competitive advantage for faster moving MedTech companies with a more competitive positioning in tenders, increased supply chain resilience, and (often) reduced operational costs. But it will not be possible to achieve Net Zero impact alone - #MedTech companies need to collaborate with peers and the broader #healthcare ecosystem to overcome barriers to decarbonisation and deliver impact at scale.   Many thanks to Oliver Bisazza and Sigrid Linher for inviting me and our climate & sustainability in healthcare experts, Elia Tziambazis and Miranda Hadfield, to lead this energizing discussion with MedTech leaders.

128

1 Kommentar

Color Health and OpenAI Collaborate to Transform Cancer Screening and Access to Expertise GenAI represents the biggest opportunity to enhance access to critical health information and services. Given the complexity and breadth of healthcare, a constant challenge is accessing expertise at crucial moments in a patient’s journey. Color Health and OpenAI have chosen to focus deeply on scaling the ability of clinicians to support a few specific, but highly impactful use cases constrained usually by access to specific experts. Their approach is unique in 3 several ways: 1/. Rather than going broad, they are focusing narrowly and deeply on a couple of specific use cases. This 'depth over breadth' strategy could be highly impactful. 2/. Cancer expertise is often scarce and absent when required along the patent journey. This solution aims to bring an oncologist's expertise into primary care interactions. 3/. The "copilot" product design approach should ensure that doctors do not experience the tool as a new piece of software, but rather as something that seamlessly integrates into their current workflow. Overall, this is a significant step in the right direction and supports our ability to 'do more with less'. I will be following this collaboration closely. The implications are immense for a range of areas beyond Cancer. #healthcare #artificialintelligence #AI #GenAI #Cancer #NHS https://lnkd.in/e-wzzeM4

10

The genomics industry is at a critical juncture. As sequencing costs fall and multi-omics gain traction, NGS clinical testing labs and life science equipment firms face a fast shifting marketplace. My BCG colleagues recent analysis investigates two possible outcomes: market contraction caused by cost erosion or expansion driven by content distinction. Learn more about the changing competitive dynamics and how to manage this new era of genomics: https://on.bcg.com/3zoUaCQ

10

The emergence of new modalities like antibody-drug conjugates (ADCs) introduces significant opportunities, challenges, and risks for drug developers. As these technologies evolve, selecting the right moment to increase investments is critical. A recent review by colleagues at BCG provides a deep dive into the ADC landscape, offering perspectives recent innovations across next-gen payloads, carriers, linkers, and conjugation techniques.

14

Join us for an insightful webinar where we will delve into the rapidly evolving dynamics of Healthcare and Life Sciences at Bain. With the advancement of digital technology and generative AI, our Healthcare and Life Sciences consulting expertise has reached new heights, enabling us to drive innovation and optimize processes across the entire value chain. Our experts will share case insights from various Healthcare and Life Sciences cases, demonstrating how our cross-disciplinary approach fuels innovation, reduces costs, and optimizes digital technologies, including generative AI: https://lnkd.in/ghDbva_r

4